Skip to main content
Clinical Trials/ACTRN12620000577910
ACTRN12620000577910
Completed
未知

A cluster randomised controlled trial of a pharmacist-led intervention for people living with severe and persistent mental illness to support medication adherence, physical health and psychological wellbeing

The Pharmacy Guild of Australia0 sites351 target enrollmentMay 18, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Severe and persistent mental illness
Sponsor
The Pharmacy Guild of Australia
Enrollment
351
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 18, 2020
End Date
December 31, 2021
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Pharmacy eligibility
  • Community pharmacies will be included if they:
  • are located within the selected RCT regions;
  • be approved to dispense pharmaceutical benefits as part of the Pharmaceutical Benefits Scheme (PBS) defined in Section 90 of the National Health Act 1953 (Cth) (Section 90 Pharmacy);
  • are accredited against Quality Care Community Pharmacy Standard (AS85000\);
  • have a demographic of clientele that includes consumers living with SPMI;
  • routinely provide MedsCheck as an established professional service (i.e. MedsCheck is not a new service in the pharmacy);
  • can guarantee that the PharMIbridge intervention is carried out by a Registered Pharmacist that has successfully completed the training and any consultations are undertaken with the consumer and/or the consumer’s carer with consideration of the consumer’s comfort and right to privacy
  • have a private consultation room or area for confidential conversations and assessments;
  • consent (by the pharmacy owner/manager) to participate; and,

Exclusion Criteria

  • Pharmacies will be excluded from the RCT if they:
  • are not located within the selected RCT regions;
  • would find it particularly difficult to recruit the required number of consumer participants living with a SPMI (i.e. do not see many of these consumers);
  • do not currently provide or a regular provider of a MedsCheck service;
  • do not have a private consultation area where conversations and assessments can be kept confidential;
  • do not actively engage with other healthcare professionals (e.g. local GP) or mental health care teams; and,
  • do not have approval to participate from the pharmacy owner or manager.
  • Consumers will be excluded from participating in the RCT if they:
  • are aged under 16 years;
  • have unstable mental health symptoms as recognised by the pharmacist or deemed unsuitable for participation by their treating healthcare professional or carer;

Outcomes

Primary Outcomes

Not specified

Similar Trials